Responses and Dialogue: Response to “Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol 4, No 3.) [Book Review]

&
Cambridge Quarterly of Healthcare Ethics 5 (3):450-457 (1996)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1017/s0963180100007283

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,779

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Responses and Dialogue: Response to “Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman. [REVIEW]Matthew D. Bacchetta & Gerd Richter - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):450.
Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol 4, No 3). [REVIEW]Imre Szebik - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (3):369-374.
Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman. [REVIEW]Helen Watt - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (1):88-96.
Response to “Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation” by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol 4, No 3) Altering the Mitochondrial Genome: Is it Just a Technical Issue? [REVIEW]Imre Szebik - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (3):369-374.
Response to “Dimensions and Classification of Genetic Interventions in the Human Genome” by Matthew D. Bacchetta and Gerd Richter - Misinterpretations and Misrepresentations.Donald S. Rubenstein - 1998 - Cambridge Quarterly of Healthcare Ethics 7 (1):90-93.
Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation.Donald S. Rubenstein, David C. Thomasma, Eric A. Schon & Michael J. Zinaman - 1995 - Cambridge Quarterly of Healthcare Ethics 4 (3):316.
Response to “Dimensions and Classification of Genetic Interventions in the Human Genome” by Matthew D. Bacchetta and Gerd Richter. [REVIEW]Donald S. Rubenstein - 1998 - Cambridge Quarterly of Healthcare Ethics 7 (1):90-93.
Germ-line therapy for mitochondrial disease: some ethical objections.Helen Watt - 1999 - Cambridge Quarterly of Healthcare Ethics 8 (1):88.
Edmund D. Pellegrino on the future of bioethics. Interview by David C Thomasma.E. D. Pellegrino - 1996 - Cambridge Quarterly of Healthcare Ethics 6 (4):373-375.
""Response to" Institutional morality, authority, and ethics committees: how far should respect for institutional morality go?" by Erich Loewy (CQ vol. 3, no. 4). [REVIEW]P. B. Hofmann - 1994 - Cambridge Quarterly of Healthcare Ethics 4 (1):98-99.

Analytics

Added to PP
2014-03-29

Downloads
3 (#1,730,340)

6 months
1 (#1,720,529)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Ethical Issues in Human Gene Therapy.LeRoy Walters - 1991 - Journal of Clinical Ethics 2 (4):267-274.

Add more references